145 related articles for article (PubMed ID: 38231156)
1. Molecular Subtypes of Bladder Cancer: Component Signatures and Potential Value in Clinical Decision-making.
Warrick J
Adv Anat Pathol; 2024 May; 31(3):178-187. PubMed ID: 38231156
[TBL] [Abstract][Full Text] [Related]
2. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
[TBL] [Abstract][Full Text] [Related]
3. A molecular taxonomy for urothelial carcinoma.
Sjödahl G; Lauss M; Lövgren K; Chebil G; Gudjonsson S; Veerla S; Patschan O; Aine M; Fernö M; Ringnér M; Månsson W; Liedberg F; Lindgren D; Höglund M
Clin Cancer Res; 2012 Jun; 18(12):3377-86. PubMed ID: 22553347
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Power of a Tumor Differentiation Gene Signature for Bladder Urothelial Carcinomas.
Mo Q; Nikolos F; Chen F; Tramel Z; Lee YC; Hayashi K; Xiao J; Shen J; Chan KS
J Natl Cancer Inst; 2018 May; 110(5):448-459. PubMed ID: 29342309
[TBL] [Abstract][Full Text] [Related]
5. Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.
Genitsch V; Kollár A; Vandekerkhove G; Blarer J; Furrer M; Annala M; Herberts C; Pycha A; de Jong JJ; Liu Y; Krentel F; Davicioni E; Gibb EA; Kruithof-de Julio M; Wyatt AW; Seiler R
Urol Oncol; 2019 Nov; 37(11):826-836. PubMed ID: 31585777
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral Heterogeneity of Bladder Cancer by Molecular Subtypes and Histologic Variants.
Warrick JI; Sjödahl G; Kaag M; Raman JD; Merrill S; Shuman L; Chen G; Walter V; DeGraff DJ
Eur Urol; 2019 Jan; 75(1):18-22. PubMed ID: 30266310
[TBL] [Abstract][Full Text] [Related]
7. International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas.
Paner GP; Kamat A; Netto GJ; Samaratunga H; Varma M; Bubendorf L; van der Kwast TH; Cheng L;
Am J Surg Pathol; 2024 Jan; 48(1):e11-e23. PubMed ID: 37382156
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of squamous differentiation in urothelial cell carcinoma: a paradigm for molecular subtyping of urothelial cell carcinoma of the bladder.
Adam RM; DeGraff DJ
Urol Oncol; 2015 Oct; 33(10):444-50. PubMed ID: 26254697
[TBL] [Abstract][Full Text] [Related]
9. Gene Expression Profiling of Muscle-Invasive Bladder Cancer With Secondary Variant Histology.
de Jong JJ; Narayan VM; Cronican AA; Gupta S; van Leenders GJLH; Boormans JL; Gibb EA; Konety BR
Am J Clin Pathol; 2021 Oct; 156(5):895-905. PubMed ID: 34157072
[TBL] [Abstract][Full Text] [Related]
10. Urothelial Carcinoma: Divergent Differentiation and Morphologic Subtypes.
Gandhi J; Chen JF; Al-Ahmadie H
Surg Pathol Clin; 2022 Dec; 15(4):641-659. PubMed ID: 36344181
[TBL] [Abstract][Full Text] [Related]
11. A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma.
Patschan O; Sjödahl G; Chebil G; Lövgren K; Lauss M; Gudjonsson S; Kollberg P; Eriksson P; Aine M; Månsson W; Fernö M; Liedberg F; Höglund M
Eur Urol; 2015 Nov; 68(5):824-32; discussion 835-6. PubMed ID: 25770486
[TBL] [Abstract][Full Text] [Related]
12. Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer.
Guo CC; Dadhania V; Zhang L; Majewski T; Bondaruk J; Sykulski M; Wronowska W; Gambin A; Wang Y; Zhang S; Fuentes-Mattei E; Kamat AM; Dinney C; Siefker-Radtke A; Choi W; Baggerly KA; McConkey D; Weinstein JN; Czerniak B
Eur Urol; 2016 Oct; 70(4):611-620. PubMed ID: 26988609
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma.
Nakauma-González JA; Rijnders M; van Riet J; van der Heijden MS; Voortman J; Cuppen E; Mehra N; van Wilpe S; Oosting SF; Rijstenberg LL; Westgeest HM; Zwarthoff EC; de Wit R; van der Veldt AAM; van de Werken HJG; Lolkema MPJ; Boormans JL
Eur Urol; 2022 Apr; 81(4):331-336. PubMed ID: 35086719
[TBL] [Abstract][Full Text] [Related]
14. Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems.
Eriksson P; Aine M; Veerla S; Liedberg F; Sjödahl G; Höglund M
BMC Med Genomics; 2015 May; 8():25. PubMed ID: 26008846
[TBL] [Abstract][Full Text] [Related]
15. Clinical Parameters Outperform Molecular Subtypes for Predicting Outcome in Bladder Cancer: Results from Multiple Cohorts, Including TCGA.
Morera DS; Hasanali SL; Belew D; Ghosh S; Klaassen Z; Jordan AR; Wang J; Terris MK; Bollag RJ; Merseburger AS; Stenzl A; Soloway MS; Lokeshwar VB
J Urol; 2020 Jan; 203(1):62-72. PubMed ID: 31112107
[TBL] [Abstract][Full Text] [Related]
16. Variant Histology in Bladder Cancer-Current Understanding of Pathologic Subtypes.
Aron M
Curr Urol Rep; 2019 Nov; 20(12):80. PubMed ID: 31781939
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic Molecular Subclassification of Urothelial Carcinoma of the Bladder: Are We Finally there?
Akhtar M; Al-Bozom IA; Ben Gashir M; Taha NM
Adv Anat Pathol; 2019 Jul; 26(4):251-256. PubMed ID: 31188799
[TBL] [Abstract][Full Text] [Related]
18. Novel biomarkers in bladder cancer.
Cheng ML; Iyer G
Urol Oncol; 2018 Mar; 36(3):115-119. PubMed ID: 29472156
[TBL] [Abstract][Full Text] [Related]
19. RNA Expression Profiling of Lymphoepithelioma-Like Carcinoma of the Bladder Reveals a Basal-Like Molecular Subtype.
Manocha U; Kardos J; Selitsky S; Zhou M; Johnson SM; Breslauer C; Epstein JI; Kim WY; Wobker SE
Am J Pathol; 2020 Jan; 190(1):134-144. PubMed ID: 31610173
[TBL] [Abstract][Full Text] [Related]
20. Bladder Cancer in the Genomic Era.
Guo CC; Czerniak B
Arch Pathol Lab Med; 2019 Jun; 143(6):695-704. PubMed ID: 30672335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
